CURCUMIN: THE INDIAN SOLID GOLD

P1: OTE/SPH P2: OTE
SVNY332-Aggarwal December 22, 2006 16:34
CURCUMIN: THE INDIAN SOLID GOLD 45
apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol
Cancer Ther 2, 95–103 (2003).
487. A. Pol, M. Bergers, and J. Schalkwijk, Comparison of antiproliferative effects of
experimental and established antipsoriatic drugs on human keratinocytes, using a
simple 96-well-plate assay. In Vitro Cell Dev Biol Anim 39, 36–42 (2003).
488. T. Dorai, J. P. Dutcher, D. W. Dempster, and P. H. Wiernik, Therapeutic potential
of curcumin in prostate cancer–V: Interference with the osteomimetic properties of
hormone refractory C4-2B prostate cancer cells. Prostate 60, 1–17 (2004).
489. J. Holy, Curcumin inhibits cell motility and alters microfilament organization and
function in prostate cancer cells. Cell Motil Cytoskeleton 58, 253–268 (2004).
490. R. Rashmi, S. Kumar, and D. Karunagaran, Ectopic expression of Hsp70 confers resistance
and silencing its expression sensitizes human colon cancer cells to curcumininduced
apoptosis. Carcinogenesis 25, 179–187 (2004).
491. D. W. Scott and G. Loo, Curcumin-induced GADD153 gene up-regulation in human
colon cancer cells. Carcinogenesis 25, 2155–2164 (2004).
492. C. Syng-Ai, A. L. Kumari and A. Khar, Effect of curcumin on normal and tumor cells:
role of glutathione and bcl-2. Mol Cancer Ther 3, 1101–1108 (2004).
493. M. Fullbeck, X. Huang, R. Dumdey, C. Frommel, W. Dubiel, and R. Preissner, Novel
curcumin- and emodin-related compounds identified by in silico 2D/3D conformer
screening induce apoptosis in tumor cells. BMC Cancer 5, 97 (2005).
494. X. Gao, D. Deeb, H. Jiang, Y. B. Liu, S. A. Dulchavsky, and S. C. Gautam, Curcumin
differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis
through activation of procaspases and release of cytochrome c from mitochondria. J
Exp Ther Oncol 5, 39–48 (2005).
495. E. M. Jung, J. H. Lim, T. J. Lee, J. W. Park, K. S. Choi, and T. K. Kwon, Curcumin
sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced
apoptosis through reactive oxygen species-mediated upregulation of death receptor 5
(DR5). Carcinogenesis 26, 1905–1913 (2005).
496. S. Mishra, N. Kapoor, A. Mubarak Ali, B. V. Pardhasaradhi, A. L. Kumari, A. Khar,
and K. Misra, Differential apoptotic and redox regulatory activities of curcumin and
its derivatives. Free Radica Biol Med 38, 1353–1360 (2005).
497. S. D. Park, J. H. Jung, H. W. Lee, Y. M. Kwon, K. H. Chung, M. G. Kim, and C. H.
Kim, Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced
proliferation of human hepatic myofibroblasts. Int Immunopharmacol 5, 555–569
(2005).
498. R. Rashmi, S. Kumar, and D. Karunagaran, Human colon cancer cells lacking Bax
resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic
expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26, 713–723 (2005).
499. Q. Wang, A. Y. Sun, A. Simonyi, M. D. Jensen, P. B. Shelat, G. E. Rottinghaus, R. S.
MacDonald, D. K. Miller, D. E. Lubahn, G. A. Weisman, and G. Y. Sun, Neuroprotective
mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis
and behavioral deficits. J Neurosci Res 82, 138–148 (2005).
500. C. W. Lee, W. N. Lin, C. C. Lin, S. F. Luo, J. S. Wang, J. Pouyssegur, and C. M. Yang,
Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in
human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and
histone acetylation. J Cell Physiol 207, 174–186 (2006).
501. L. I. Lin, Y. F. Ke, Y. C. Ko, and J. K. Lin, Curcumin inhibits SK-Hep-1 hepatocellular
carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion.
Oncology 55, 349–353 (1998).